Q2 FY2026 EarningsQ2 FY26 results significantly beat consensus across all key metrics: revenue of $12.2M surpassed the $10.9M expected (+11.7%), while gross margin reached 40.1% vs. the 35.0% mean forecast (+5.1pct). GAAP EPS of -$0.06 beat the consensus of -$0.09. Strong performance in Lab Essentials and Clinical Solutions led to a full-year revenue guidance raise to $45-47M and a significant narrowing of Free Cash Outflow expectations.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Alpha Teknova(TKNO) the Revenue is 12.19 M (+18.45%), Beat estimate;the EBIT is -2.89 M (+14.65%), Beat estimate;the EPS is -0.06 (+14.29%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.01B18.45%
0.01B6.02%
+0.00B12.43%
EBITExceed expectations
-0.00B14.65%
-0.00B30.77%
+0.00B45.42%
EPSExceed expectations
-0.0614.29%
-0.086723.81%
+0.026738.10%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf